CRI Technology Impact Award
Seed funding of up to 300,000 USD (over two years) to bridge novel technology development and clinical application in cancer immunotherapy—supporting bioinformatics platforms, ex vivo/in silico models, profiling instrumentation, assays, and other transformative tools.
Eligibility Criteria:
-
Faculty appointment as a tenure-track assistant professor (or higher) by award activation (July 1 earliest). If appointment is pending, include institutional documentation confirming the future position.
-
Research conducted at a non-profit academic, medical, or research center (U.S. or abroad); for-profit institutions are not eligible recipients.
-
Project must describe an extraordinarily novel, creative, and technically sophisticated technology with clear potential to impact cancer immunotherapy research.
Funding Details:
-
Amount: Up to 150,000 USD per year for 2 years (maximum total $300,000)
-
Use of Funds: Salary, technical assistance, supplies, capital equipment, or scientific travel
-
Exclusions: No indirect costs; payments made quarterly in U.S. currency to the host institution
Deadlines:
-
Letter of Intent: November 15, 5 p.m. Eastern Time
-
Invited Full Application: March 3, 5 p.m. Eastern Time
-
If a deadline falls on a weekend, submissions accepted the following Monday.
-
-
Earliest Award Activation: July 1 (awards activate on the first of the month)
Where to Go for Further Information:
Submit LOIs and full proposals via the CRI Application Portal.
For questions or assistance, email [email protected].
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023